|
ICH M7 plans to harmonize AI limits for Nitrosamines
|
|
1
|
319
|
June 13, 2024
|
|
Quelles Nitrosamines la Picloxidine est-elle susceptible de former?
|
|
1
|
325
|
June 12, 2024
|
|
N-Nitroso Hydrochlorothiazide in Hydrochlorothiazide drug substance
|
|
12
|
4202
|
June 11, 2024
|
|
EMA-funded project to predict in-vivo mutagenicity / mutagenicity classification
|
|
9
|
1052
|
June 11, 2024
|
|
Nitrosamines in food raise a health concern (EFSA)
|
|
7
|
1094
|
June 11, 2024
|
|
Limit for API having two NDSRI
|
|
14
|
2422
|
June 11, 2024
|
|
Lhasa TD50 or Gold TD50 to set AI limit?
|
|
8
|
753
|
June 10, 2024
|
|
CPCA Category 5 (AI 1500 ng/day) for NDIPA by Health Canada
|
|
2
|
477
|
June 6, 2024
|
|
Examining the Use of Surrogates in Combination with The Carcinogenic Potency Categorization Approach when Establishing Acceptable Intake Limits of N-Nitrosamine Impurities
|
|
0
|
483
|
June 9, 2024
|
|
Structuring expert review using AOPs: Enabling robust weight-of-evidence assessments for carcinogenicity under ICH S1B(R1)
|
|
0
|
285
|
June 9, 2024
|
|
Aspartame and nitrosamines
|
|
4
|
470
|
June 7, 2024
|
|
Lactose, Nitrosamine Risk?
|
|
35
|
3399
|
April 6, 2022
|
|
N-nitroso derivative of pyrrole moiety in Pyrrolopyrimidines
|
|
0
|
316
|
June 6, 2024
|
|
A new root cause? NOx
|
|
13
|
1952
|
November 17, 2023
|
|
Can Activated carbon promote nitrosamine formation and lead to high Nitrosamine levels in FP?
|
|
12
|
1107
|
June 5, 2024
|
|
Update: EFPIA workflows for Quality Risk management Jun 2024 v03
|
|
2
|
970
|
June 4, 2024
|
|
Nitrosamines impurities and ICH M7
|
|
1
|
318
|
June 4, 2024
|
|
🇨🇦 Health Canada updated the guidance and Appendix 1(March 15, 2024)
|
|
11
|
3372
|
June 3, 2024
|
|
Formic acid-aided sample preparation method for sensitive and simultaneous analysis of eight nitrosamines in poorly-water soluble pharmaceutical drugs using liquid chromatography–ultraviolet detection
|
|
0
|
253
|
June 2, 2024
|
|
🇺🇸 FDA - Fiscal Year 2024 Generic Drug Science and Research Initatives Public Workshop
|
|
20
|
1952
|
September 5, 2024
|
|
🇰🇷 Case study on the Occurrence of Impurities in Pharmaceuticals (Focusing on NDMA Cases)
|
|
0
|
351
|
May 31, 2024
|
|
N-nitroso-nitrofurantoin
|
|
0
|
296
|
May 31, 2024
|
|
Formaldehyde Catalysis of Nitrosamine Formation
|
|
3
|
651
|
May 31, 2024
|
|
⚙️🌎CPCA: the gestation, birth, and development -Pub
|
|
5
|
1170
|
May 31, 2024
|
|
Justify the presence of amine in the API chemical structure
|
|
3
|
313
|
May 29, 2024
|
|
🇲🇽 Conferencia USP Nitrosaminas en México presencial 21-Marzo
|
|
4
|
780
|
May 27, 2024
|
|
AI limit of API having very law MDD
|
|
1
|
350
|
May 27, 2024
|
|
FDA releases FY23 GDUFA Science and Research Report
|
|
0
|
278
|
May 24, 2024
|
|
Namibia Medicines Regulatory council (NMRC) has withdrawn all ranitidine products from the Namibian market
|
|
0
|
229
|
May 23, 2024
|
|
N-nitrososarcosine limit
|
|
5
|
694
|
May 23, 2024
|